SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-08-084922
Filing Date
2008-04-18
Accepted
2008-04-18 17:25:56
Documents
4
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT NO. 1 d10ka.htm 10-K/A 510713
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 7335
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 7731
4 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 7355
  Complete submission text file 0001193125-08-084922.txt   534554
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-12465 | Film No.: 08765327
SIC: 2834 Pharmaceutical Preparations